Mitochondrial oxidative stress, mitochondrial ROS storms in long COVID pathogenesis
暂无分享,去创建一个
T. Kanekura | V. Nissapatorn | K. Bunluepuech | M. Kotepui | Fumitaka Kawakami | Jitbanjong Tangpong | H. Indo | Moragot Chatatikun | S. Surinkaew | Voravuth Somsak | Suriyan Sukati | R. Hossain | Motoki Imai | Wiyada Kwanhian Klangbud | Lunla Udomwech | Kunwadee Noonong | Aman Tedasen | Takafumi Ichikawa | Chanittha Noothong | Makoto Kubo | Yoshimasa Kitagawa | Hiroshi Ichikawa | Hideyuki J Majima
[1] A. Murueta-Goyena,et al. Dysautonomia and small fiber neuropathy in post-COVID condition and Chronic Fatigue Syndrome , 2023, Journal of Translational Medicine.
[2] Weiwei Xia,et al. Mitochondrial antiviral signaling protein: a potential therapeutic target in renal disease , 2023, Frontiers in immunology.
[3] Larry N. Singh,et al. Core mitochondrial genes are down-regulated during SARS-CoV-2 infection of rodent and human hosts , 2023, Science Translational Medicine.
[4] R. Mandal,et al. The plasma metabolome of long COVID patients two years after infection , 2023, Scientific reports.
[5] David M. Liebovitz,et al. Outpatient treatment of COVID-19 and incidence of post-COVID-19 condition over 10 months (COVID-OUT): a multicentre, randomised, quadruple-blind, parallel-group, phase 3 trial , 2023, The Lancet Infectious Diseases.
[6] Tsung-Hsien Chen,et al. Possible Pathogenesis and Prevention of Long COVID: SARS-CoV-2-Induced Mitochondrial Disorder , 2023, International journal of molecular sciences.
[7] F. Taghizadeh-Hesary,et al. COVID-19 induced liver injury from a new perspective: Mitochondria , 2023, Mitochondrion.
[8] D. Colangelo,et al. COVID-19 Biomarkers at the Crossroad between Patient Stratification and Targeted Therapy: The Role of Validated and Proposed Parameters , 2023, International journal of molecular sciences.
[9] A. Acquaviva,et al. Decreased Gas6 and sAxl Plasma Levels Are Associated with Hair Loss in COVID-19 Survivors , 2023, International journal of molecular sciences.
[10] E. Topol,et al. Long COVID: major findings, mechanisms and recommendations , 2023, Nature Reviews Microbiology.
[11] T. Zaehle,et al. The therapeutic potential of non-invasive brain stimulation for the treatment of Long-COVID-related cognitive fatigue , 2023, Frontiers in Immunology.
[12] K. Thangaraj,et al. Severe acute respiratory syndrome coronaviruses contributing to mitochondrial dysfunction: Implications for post-COVID complications , 2023, Mitochondrion.
[13] G. Cappellano,et al. Determinants of long COVID among adults hospitalized for SARS-CoV-2 infection: A prospective cohort study , 2022, Frontiers in Immunology.
[14] Julie Dee Bell,et al. Understanding Long COVID; Mitochondrial Health and Adaptation—Old Pathways, New Problems , 2022, Biomedicines.
[15] V. Chinchilli,et al. Association of COVID-19 with diabetes: a systematic review and meta-analysis , 2022, Scientific Reports.
[16] Rudranil De,et al. Pathophysiological involvement of host mitochondria in SARS-CoV-2 infection that causes COVID-19: a comprehensive evidential insight , 2022, Molecular and Cellular Biochemistry.
[17] P. Lotufo,et al. Post-COVID syndrome, inflammation, and diabetes , 2022, Journal of Diabetes and its Complications.
[18] D. Colangelo,et al. CGRP Plasma Levels Correlate with the Clinical Evolution and Prognosis of Hospitalized Acute COVID-19 Patients , 2022, Viruses.
[19] C. Duan,et al. SARS-CoV-2 Achieves Immune Escape by Destroying Mitochondrial Quality: Comprehensive Analysis of the Cellular Landscapes of Lung and Blood Specimens From Patients With COVID-19 , 2022, Frontiers in Immunology.
[20] J. A. Rock,et al. Diabetes and COVID-19: Short- and Long-Term Consequences , 2022, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.
[21] C. Steves,et al. Risk of long COVID associated with delta versus omicron variants of SARS-CoV-2 , 2022, The Lancet.
[22] Z. Al-Aly,et al. Long COVID after breakthrough SARS-CoV-2 infection , 2022, Nature Medicine.
[23] D. Lilleri,et al. Baseline Plasma Gas6 Protein Elevation Predicts Adverse Outcomes in Hospitalized COVID-19 Patients , 2022, Disease markers.
[24] K. Kraft,et al. Oxidative Stress and Hyper-Inflammation as Major Drivers of Severe COVID-19 and Long COVID: Implications for the Benefit of High-Dose Intravenous Vitamin C , 2022, Frontiers in Pharmacology.
[25] G. Muscogiuri,et al. Vitamin D: A Role Also in Long COVID-19? , 2022, Nutrients.
[26] Yan Xie,et al. Risks and burdens of incident diabetes in long COVID: a cohort study , 2022, The Lancet Diabetes & Endocrinology.
[27] D. Lilleri,et al. Prognostic Markers in Hospitalized COVID-19 Patients: The Role of IP-10 and C-Reactive Protein , 2022, Disease markers.
[28] P. Pfeffer,et al. A clinical review of long-COVID with a focus on the respiratory system , 2022, Current opinion in pulmonary medicine.
[29] Peihui Wang,et al. SARS-CoV-2 membrane protein causes the mitochondrial apoptosis and pulmonary edema via targeting BOK , 2022, Cell Death & Differentiation.
[30] G. Lippi,et al. Blood lactate concentration in COVID-19: a systematic literature review , 2021, Clinical chemistry and laboratory medicine.
[31] S. Karim,et al. Omicron SARS-CoV-2 variant: a new chapter in the COVID-19 pandemic , 2021, The Lancet.
[32] I. Merfort,et al. Identification of an ASC oligomerization inhibitor for the treatment of inflammatory diseases , 2021, Cell Death & Disease.
[33] Ling Zhu,et al. The Triangle Relationship Between Long Noncoding RNA, RIG-I-like Receptor Signaling Pathway, and Glycolysis , 2021, Frontiers in Microbiology.
[34] J. Lagier,et al. Long-term persistence of symptoms of dyspnoea in COVID-19 patients , 2021, International Journal of Infectious Diseases.
[35] M. Farzan,et al. Mechanisms of SARS-CoV-2 entry into cells , 2021, Nature reviews. Molecular cell biology.
[36] Meeta Gupta,et al. A Systematic Review and Meta-analysis of Diabetes Associated Mortality in Patients with COVID-19 , 2021, International journal of endocrinology and metabolism.
[37] M. Martinez-Fierro,et al. Mitochondria and Mitochondrial DNA: Key Elements in the Pathogenesis and Exacerbation of the Inflammatory State Caused by COVID-19 , 2021, Medicina.
[38] S. Snyder,et al. Redox imbalance links COVID-19 and myalgic encephalomyelitis/chronic fatigue syndrome , 2021, Proceedings of the National Academy of Sciences.
[39] Ilene S Ruhoy,et al. Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Essentials of Diagnosis and Management. , 2021, Mayo Clinic proceedings.
[40] P. Edison,et al. Long covid—mechanisms, risk factors, and management , 2021, BMJ.
[41] G. Cui,et al. Saving critically ill COVID-19 patients with mechanical circulatory support , 2021, Annals of translational medicine.
[42] S. Safiri,et al. Potency of BNT162b2 and mRNA‐1273 vaccine‐induced neutralizing antibodies against severe acute respiratory syndrome‐CoV‐2 variants of concern: A systematic review of in vitro studies , 2021, Reviews in medical virology.
[43] T. Burki. Lifting of COVID-19 restrictions in the UK and the Delta variant , 2021, The Lancet Respiratory Medicine.
[44] J. Gameiro,et al. Impact of Chronic RAAS Use in Elderly COVID-19 Patients: A Retrospective Analysis , 2021, Journal of clinical medicine.
[45] V. Pravica,et al. Immune Evasion of SARS-CoV-2 Emerging Variants: What Have We Learnt So Far? , 2021, Viruses.
[46] N. Secher,et al. The role of lactate in sepsis and COVID‐19: Perspective from contracting skeletal muscle metabolism , 2021, Experimental physiology.
[47] A. Cumpstey,et al. COVID-19 - A Redox Disease What a Stress Pandemic Can Teach Us About Resilience and What We May Learn from the Reactive Species Interactome About its Treatment. , 2021, Antioxidants & redox signaling.
[48] R. Jayadevan,et al. Long COVID: An overview , 2021, Diabetes & Metabolic Syndrome: Clinical Research & Reviews.
[49] P. Prasun. COVID-19: A Mitochondrial Perspective. , 2021, DNA and cell biology.
[50] R. H. Al-Rifai,et al. Diabetes prevalence and mortality in COVID-19 patients: a systematic review, meta‐analysis, and meta‐regression , 2021, Journal of Diabetes & Metabolic Disorders.
[51] D. Brodie,et al. Post-acute COVID-19 syndrome , 2021, Nature Medicine.
[52] A. Iwasaki,et al. The first 12 months of COVID-19: a timeline of immunological insights , 2021, Nature reviews. Immunology.
[53] David A. Drew,et al. Attributes and predictors of long COVID , 2021, Nature Medicine.
[54] S. Valdivieso,et al. Role of neutrophil-to-lymphocyte, lymphocyte-to-monocyte and platelet-to-lymphocyte ratios as predictors of disease severity in COVID-19 patients. , 2021, Le infezioni in medicina.
[55] A. Salonia,et al. Diabetes is most important cause for mortality in COVID-19 hospitalized patients: Systematic review and meta-analysis , 2021, Reviews in Endocrine and Metabolic Disorders.
[56] A. Pandey,et al. Roles of host mitochondria in the development of COVID-19 pathology: Could mitochondria be a potential therapeutic target? , 2021, Molecular Biomedicine.
[57] P. Reddy,et al. Impact of COVID-19 on Mitochondrial-Based Immunity in Aging and Age-Related Diseases , 2021, Frontiers in Aging Neuroscience.
[58] P. Cohen,et al. Host mitochondrial transcriptome response to SARS-CoV-2 in multiple cell models and clinical samples , 2021, Scientific Reports.
[59] A. Hussain,et al. Determinants of in-hospital mortality in COVID-19; a prospective cohort study from Pakistan , 2021, medRxiv.
[60] R. Pranata,et al. Prognostic value of elevated lactate dehydrogenase in patients with COVID-19: a systematic review and meta-analysis , 2021, Postgraduate Medical Journal.
[61] Tezcan Akın,et al. Efficacy of the delta neutrophil index in predicting 30‐day mortality in COVID‐19 patients requiring intensive care , 2020, International journal of clinical practice.
[62] E. Wood,et al. Role of mitochondria, oxidative stress and the response to antioxidants in myalgic encephalomyelitis/chronic fatigue syndrome: A possible approach to SARS-CoV-2 ‘long-haulers’? , 2020, Chronic Diseases and Translational Medicine.
[63] Amish Talwar,et al. A Proposed Framework and Timeline of the Spectrum of Disease Due to SARS-CoV-2 Infection: Illness Beyond Acute Infection and Public Health Implications. , 2020, JAMA.
[64] G. López-Lluch,et al. Age-related mitochondrial dysfunction as a key factor in COVID-19 disease , 2020, Experimental Gerontology.
[65] M. Mcphail,et al. Mitochondrial metabolic manipulation by SARS-CoV-2 in peripheral blood mononuclear cells of patients with COVID-19 , 2020, American journal of physiology. Cell physiology.
[66] V. Thiel,et al. Coronavirus biology and replication: implications for SARS-CoV-2 , 2020, Nature Reviews Microbiology.
[67] Z. Memish,et al. Clinical Characteristics and Predictors of 28-Day Mortality in 352 Critically Ill Patients with COVID-19: A Retrospective Study , 2020, Journal of epidemiology and global health.
[68] I. Dimopoulou,et al. Lactate Kinetics Reflect Organ Dysfunction and Are Associated with Adverse Outcomes in Intensive Care Unit Patients with COVID-19 Pneumonia: Preliminary Results from a GREEK Single-Centre Study , 2020, Metabolites.
[69] H. Nikzad,et al. The novel coronavirus Disease-2019 (COVID-19): Mechanism of action, detection and recent therapeutic strategies , 2020, Virology.
[70] S. Hussain,et al. Burden of diabetes mellitus and its impact on COVID-19 patients: A meta-analysis of real-world evidence , 2020, Diabetes & Metabolic Syndrome: Clinical Research & Reviews.
[71] B. Tang,et al. Diabetes Mellitus is Associated with Severe Infection and Mortality in Patients with COVID-19: A Systematic Review and Meta-analysis , 2020, Archives of Medical Research.
[72] Xiaochen Li,et al. Abnormal immunity of non-survivors with COVID-19: predictors for mortality , 2020, Infectious Diseases of Poverty.
[73] Wei Wang,et al. Hyperglycemia is a strong predictor of poor prognosis in COVID-19 , 2020, Diabetes Research and Clinical Practice.
[74] M. Antonelli,et al. Prognostic factors associated with mortality risk and disease progression in 639 critically ill patients with COVID-19 in Europe: Initial report of the international RISC-19-ICU prospective observational cohort , 2020, EClinicalMedicine.
[75] G. Chaubey,et al. Decoding SARS-CoV-2 hijacking of host mitochondria in COVID-19 pathogenesis , 2020, American journal of physiology. Cell physiology.
[76] F. Violi,et al. COVID-19 and cardiovascular injury: A role for oxidative stress and antioxidant treatment? , 2020, International Journal of Cardiology.
[77] D. Kokkinidis,et al. Diabetes is associated with increased risk for in-hospital mortality in patients with COVID-19: a systematic review and meta-analysis comprising 18,506 patients , 2020, Hormones.
[78] L. Delgado-Roche,et al. Oxidative Stress as Key Player in Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) Infection , 2020, Archives of Medical Research.
[79] Howard Y. Chang,et al. RNA-GPS Predicts SARS-CoV-2 RNA Localization to Host Mitochondria and Nucleolus , 2020, bioRxiv.
[80] Li Zhang,et al. Summary of 20 tracheal intubation by anesthesiologists for patients with severe COVID-19 pneumonia: retrospective case series , 2020, Journal of Anesthesia.
[81] Dong Men,et al. Detectable Serum Severe Acute Respiratory Syndrome Coronavirus 2 Viral Load (RNAemia) Is Closely Correlated With Drastically Elevated Interleukin 6 Level in Critically Ill Patients With Coronavirus Disease 2019 , 2020, Clinical Infectious Diseases.
[82] Kiran Bavirisetti. Review of "A pneumonia outbreak associated with a new coronavirus of probable bat origin" , 2020 .
[83] Xiang Li,et al. On the origin and continuing evolution of SARS-CoV-2 , 2020, National science review.
[84] Dong Men,et al. Detectable serum SARS-CoV-2 viral load (RNAaemia) is closely correlated with drastically elevated interleukin 6 (IL-6) level in critically ill COVID-19 patients , 2020, medRxiv.
[85] T. Jiang,et al. The deadly coronaviruses: The 2003 SARS pandemic and the 2020 novel coronavirus epidemic in China , 2020, Journal of Autoimmunity.
[86] Zunyou Wu,et al. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. , 2020, JAMA.
[87] Yan Zhao,et al. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. , 2020, JAMA.
[88] E. Holmes,et al. A new coronavirus associated with human respiratory disease in China , 2020, Nature.
[89] Kai Zhao,et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin , 2020, Nature.
[90] E. Holmes,et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding , 2020, The Lancet.
[91] Ting Yu,et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study , 2020, The Lancet.
[92] G. Gao,et al. A Novel Coronavirus from Patients with Pneumonia in China, 2019 , 2020, The New England journal of medicine.
[93] Y. Hu,et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China , 2020, The Lancet.
[94] S. Lo,et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster , 2020, The Lancet.
[95] Yuan He,et al. The NLRP3 Inflammasome: An Overview of Mechanisms of Activation and Regulation , 2019, International journal of molecular sciences.
[96] Junbo Hu,et al. Lactate Is a Natural Suppressor of RLR Signaling by Targeting MAVS , 2019, Cell.
[97] Sachin Kumar,et al. Organelle dynamics and viral infections: at cross roads , 2018, Microbes and Infection.
[98] C. Claus,et al. A renewed focus on the interplay between viruses and mitochondrial metabolism , 2013, Archives of Virology.
[99] S. Tikoo,et al. Viruses as Modulators of Mitochondrial Functions , 2013, Advances in virology.
[100] S. Jameel,et al. Severe acute respiratory syndrome coronavirus 3a protein activates the mitochondrial death pathway through p38 MAP kinase activation. , 2008, The Journal of general virology.
[101] H. Majima,et al. Evidence of ROS generation by mitochondria in cells with impaired electron transport chain and mitochondrial DNA damage. , 2007, Mitochondrion.
[102] Umair Mallick. Pathogenesis of CoViD19—Miscellaneous Mechanisms , 2022, Cardiovascular Complications of COVID-19.